免疫グロブリン市場レポート 製品別(IgG、IgA、IgM、IgE、IgD)、用途別(低ガンマグロブリン血症、慢性炎症性脱髄性多発神経炎(CIDP)、免疫不全症、重症筋無力症、その他)、送達様式別(静脈内送達様式、皮下送達様式)、地域別 2025-2033

免疫グロブリン市場レポート 製品別(IgG、IgA、IgM、IgE、IgD)、用途別(低ガンマグロブリン血症、慢性炎症性脱髄性多発神経炎(CIDP)、免疫不全症、重症筋無力症、その他)、送達様式別(静脈内送達様式、皮下送達様式)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A24770

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Immunoglobulin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    IgG
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    IgA
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    IgM
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    IgE
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    IgD
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Application
    7.1    Hypogammaglobulinemia
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunodeficiency Disease
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Myasthenia Gravis
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Mode of Delivery
    8.1    Intravenous Mode of Delivery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Subcutaneous Mode of Delivery
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    ADMA Biologics Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Baxter international Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Biotest AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    CSL Limited
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Grifols S.A
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Kedrion S.p.A
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    LFB SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Octapharma AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 SWOT Analysis
        14.3.9    Sanquin Plasma Products B.V.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Takeda Pharmaceutical Company Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

免疫グロブリン市場レポート 製品別(IgG、IgA、IgM、IgE、IgD)、用途別(低ガンマグロブリン血症、慢性炎症性脱髄性多発神経炎(CIDP)、免疫不全症、重症筋無力症、その他)、送達様式別(静脈内送達様式、皮下送達様式)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials